On October 1, 2013, seven national councils representing French health care professionals posted on their publicly accessible websites information submitted by affected enterprises (i.e., companies) that produce or market medications, medical devices, biomaterials, and other therapeutic and cosmetic products about benefits granted to and agreements concluded with French health care professionals, as required by Article L. 1453.1 of the French Public Health Code (PHC).
The disclosure obligation is imposed by Article 2 of Law No. 2011-2012 Regarding the Reinforcement of the Safety of Medicinal and Health Products (known as the “Bertrand Act” or “French Sunshine Act”) as implemented by Decree no. 2013-414 Concerning the Transparency of Benefits Granted by Enterprises Producing or Marketing Sanitary and Cosmetic Products Intended for Human Use (“Implementing Decree”).
Please see full publication below for more information.
